InSightec: Funding, Investors & Team (Sep 2026)
InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery. ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.
InSightec has raised $400M across 3 funding rounds on record, the most recent an undisclosed round of $150M announced in Jun 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
InSightec Company Profile and Key Stats
Latest funding round on record: Jun 2024.
InSightec Funding Rounds
InSightec raised $150M in an undisclosed round announced in Mar 2020.
2.5 years later, a Debt Financing of $100M was announced in Sep 2022.
1.8 years later, an undisclosed round of $150M was announced in Jun 2024.
InSightec Founders and Leadership Team
No contact details are on record for this team yet.
InSightec Funding Compared to Other Biotechnology Startups
InSightec's latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like InSightec in Biotechnology and Tirat Carmel
Companies Similar to InSightec
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
InSightec Funding FAQs
What does InSightec do?
InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery. ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.
How much funding has InSightec raised?
InSightec has raised $400M across 3 rounds on record. The most recent is an undisclosed round of $150M announced in Jun 2024.
When did InSightec last raise funding?
InSightec's most recent funding round on record is an undisclosed round of $150M, announced in Jun 2024.
Who founded InSightec?
FundedIQ lists Kobi Vortman (Founder) at InSightec.
Who is the CEO of InSightec?
Maurice Ferre is listed as CEO at InSightec.
Where is InSightec headquartered?
InSightec is based in Tirat Carmel, Hefa, Israel.
How many employees does InSightec have?
InSightec is in the 251-500 employee band.
How does InSightec's funding compare to other Biotechnology startups?
InSightec's latest round of $150M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's InSightec Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for InSightec is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.